Karus Therapeutics features in Biology Impacting Lives programme

Oxfordshire, UK, 11 October 2019 – Karus Therapeutics, a clinical-stage biopharmaceutical company developing precision medicines for cancer, was featured in the Biology Impacting Lives programme for its work towards developing precision medicines to target bile duct cancer. The programme from ITN Productions in partnership with the Royal Society of Biology features key industry interviews and […]

Karus Therapeutics features in BioCentury Innovations

Oxford, UK, 4 November 2016 – Karus Therapeutics, a leader in the design and development of innovative cancer therapeutics, was featured in BioCentury Innovations, ‘One Plus One Equals Four’. Chief Scientific Officer Stephen Shuttleworth details how lead program KA2237 can suppress tumor growth and metastasis directly, while dialing down PD-L1 and Tregs via different mechanisms […]

Karus Therapeutics features in SciBX

Oxford, UK, 15 May 2014 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, was featured in the cover story of SciBX, ‘Chromatin’s rising tide’.  The article, which covers the discussions of a panel of thought leaders at the SciBX Summit on Innovation in Drug […]

Karus Therapeutics showcased in BVCA’s Britain’s Hot Talents 2014/15

Oxford, UK, February 2014 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has been featured in the British Private Equity and Venture Capital Association (BVCA)’s handbook of venture capital innovation, Britain’s Hot Talent. In its third edition, Britain’s Hot Talent showcases venture capital in […]

Karus Therapeutics interviewed by Pharma Television

Oxford, UK, 17 July 2013 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, was interviewed about its pioneering work in the HDAC and PI3K arena. Dr Simon Kerry, Karus’s CEO discussed the Company’s plans to develop current programmes using its substantial financing backing with […]

Karus Therapeutics features on BBC South News

Oxford, UK, 15 May 2013 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, was featured on BBC South Today to highlight the importance of attracting venture capital financing to support the research and development of early stage biotechnology companies in the Oxfordshire area. The […]

Karus CEO talks to Pharma TV

Karus CEO talks to Pharma TV